Gaucher Disease - 48 Studies Found
| Completed |
: Study to Evaluate Blood Cell Lines From Patients With Gaucher Disease : Gaucher Disease : 2006-07-10 : Procedure: Blood sample |
| Completed |
: Effects of Enzyme Replacement in Gaucher's Disease : Gaucher's Disease : 1999-11-03 |
| Not yet recruiting |
: Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease : Type 1 Gaucher Disease : 2016-09-23 : Drug: Elelyso 60 units/kg All patients receive Elelyso 60 units/kg. |
| Suspended |
: Clinical Trial of Ambroxol in Patients With Type I Gaucher Disease : Type I Gaucher Disease : 2011-10-27 : Drug: Ambroxol Ambroxol at a dose level of 187.5 or 225 mg/day will be given once daily by mouth for 2 m |
| Recruiting |
: Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1) : Gaucher Disease Type 1 : 2015-08-21 : Drug: N-acetylcysteine 1800mg NAC twice daily (3600mg/day) orally for approximately 90 days. |
| Completed |
: PEG-Glucocerebrosidase for the Treatment of Gaucher Disease : Gaucher's Disease : 1999-11-03 : Drug: Lysodase |
| Completed |
: A Study to Evaluate and Characterize the Effect of Pharmacological Chemicals on Blood From Patients With Gaucher Disease : Gaucher Disease : 2007-04-21 |
| No longer available |
: Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease : Gaucher Disease : 2009-08-18 : Drug: Plant cell expressed recombinant glucocerebrosidase (prGCD) Intravenous infusion every two weeks a |
| Completed |
: OGT 918-006: A Phase I/II Randomized, Controlled Study of OGT 918 in Patients With Neuronopathic Gaucher Disease : Gaucher Disease : 2002-07-09 : Drug: OGT 918 |
| Recruiting |
: Home Therapy With VPRIV in Gaucher's Disease : Gaucher Disease : 2011-05-17 |